Search research articles
Contact Us
Filters
Showing results (241-250 of 261) with videos related to
Page
of 27
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 13, 2013
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
Raoul A Droeser, Christian Hirt, Carsten T Viehl, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 27, 2017
Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016
Alessandro Lugli, Richard Kirsch, Yoichi Ajioka, et al.
The Journal of Clinical Investigation
|
December 17, 2020
Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancer
Yuchen Guo, Monica Gabola, Rossano Lattanzio, et al.
Elife
|
October 5, 2017
The ESRP1-GPR137 axis contributes to intestinal pathogenesis
Lukas Franz Mager, Viktor Hendrik Koelzer, Regula Stuber, et al.
Nature Communications
|
January 18, 2023
Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma
L Paige Ferguson, Jovylyn Gatchalian, Matthew L McDermott, et al.
BMC Cancer
|
April 13, 2022
Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer
Sanne Ten Hoorn, Cynthia Waasdorp, Martijn G H van Oijen, et al.
Virchows Archiv : an International Journal of Pathology
|
March 2, 2021
Improving tumor budding reporting in colorectal cancer: a Delphi consensus study
Tariq Sami Haddad, Alessandro Lugli, Susan Aherne, et al.
Frontiers in Immunology
|
December 23, 2021
Rhesus Macaque CODEX Multiplexed Immunohistochemistry Panel for Studying Immune Responses During Ebola Infection
Sizun Jiang, Nilanjan Mukherjee, Richard S Bennett, et al.
Cancers
|
August 26, 2023
Multi-Institutional Evaluation of Pathologists' Assessment Compared to Immunoscore
Joseph Willis, Robert A Anders, Toshihiko Torigoe, et al.
EMBO Molecular Medicine
|
August 21, 2024
Novel immunotherapeutics against LGR5 to target multiple cancer types
Hung-Chang Chen, Nico Mueller, Katherine Stott, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 261) with videos related to
Sort By:
Page
of 27
European Journal of Cancer (Oxford, England : 1990)
|
March 13, 2013
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
Raoul A Droeser, Christian Hirt, Carsten T Viehl, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 27, 2017
Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016
Alessandro Lugli, Richard Kirsch, Yoichi Ajioka, et al.
The Journal of Clinical Investigation
|
December 17, 2020
Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancer
Yuchen Guo, Monica Gabola, Rossano Lattanzio, et al.
Elife
|
October 5, 2017
The ESRP1-GPR137 axis contributes to intestinal pathogenesis
Lukas Franz Mager, Viktor Hendrik Koelzer, Regula Stuber, et al.
Nature Communications
|
January 18, 2023
Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma
L Paige Ferguson, Jovylyn Gatchalian, Matthew L McDermott, et al.
BMC Cancer
|
April 13, 2022
Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer
Sanne Ten Hoorn, Cynthia Waasdorp, Martijn G H van Oijen, et al.
Virchows Archiv : an International Journal of Pathology
|
March 2, 2021
Improving tumor budding reporting in colorectal cancer: a Delphi consensus study
Tariq Sami Haddad, Alessandro Lugli, Susan Aherne, et al.
Frontiers in Immunology
|
December 23, 2021
Rhesus Macaque CODEX Multiplexed Immunohistochemistry Panel for Studying Immune Responses During Ebola Infection
Sizun Jiang, Nilanjan Mukherjee, Richard S Bennett, et al.
Cancers
|
August 26, 2023
Multi-Institutional Evaluation of Pathologists' Assessment Compared to Immunoscore
Joseph Willis, Robert A Anders, Toshihiko Torigoe, et al.
EMBO Molecular Medicine
|
August 21, 2024
Novel immunotherapeutics against LGR5 to target multiple cancer types
Hung-Chang Chen, Nico Mueller, Katherine Stott, et al.
Page
of 27